S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q2 2022

Perceptive Advisors

Period: Q2 2022 Β· Filed: 2022-08-15
View on SEC EDGAR β†—
AUM
$3.19B
Total portfolio value
Positions
111
Reported securities
Top Holding
14.3% $455.9M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-08-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
TRAVERE THERAPEUTICS INC$455.9M14.28%β€”β€”
14.3%
FOLDAMICUS THERAPEUTICS INC$288.9M9.05%β€”β€”
9.1%
MRTXMIRATI THERAPEUTICS INC$192.4M6.03%β€”β€”
6.0%
CERECEREVEL THERAPEUTICS HLDNG I$134.5M4.21%β€”β€”
4.2%
IOVAIOVANCE BIOTHERAPEUTICS INC$130.6M4.09%$11.04$4.31-61.0%
4.1%
LIANYLIANBIO$122.2M3.83%$0.00$0.12
3.8%
CRNXCRINETICS PHARMACEUTICALS IN$99.2M3.11%$18.65$42.23+126.4%
3.1%
GBTGLOBAL BLOOD THERAPEUTICS IN$96.3M3.02%β€”β€”
3.0%
SWTXSPRINGWORKS THERAPEUTICS INC$95.2M2.98%β€”β€”
3.0%
AMLXAMYLYX PHARMACEUTICALS INC$68.2M2.14%$19.26$18.27-5.1%
2.1%
XENEXENON PHARMACEUTICALS INC$64.6M2.02%$30.42$60.96+100.4%
2.0%
MGTXMEIRAGTX HLDGS PLC$52.7M1.65%$7.57$13.92+83.9%
1.6%
LYRAXXXXLYRA THERAPEUTICS INC$51.7M1.62%β€”β€”
1.6%
BLUBELLUS HEALTH INC NEW$51.1M1.60%β€”β€”
1.6%
RXDXPROMETHEUS BIOSCIENCES INC$47.5M1.49%β€”β€”
1.5%
ALBOALBIREO PHARMA INC$46.9M1.47%β€”β€”
1.5%
CINCCINCOR PHARMA INC$43.7M1.37%β€”β€”
1.4%
VBIVXXXXVBI VACCINES INC CDA$42.3M1.33%β€”β€”
1.3%
SGENSEAGEN INC$39.6M1.24%β€”β€”
1.2%
VERUXXXXVERU INC$39.5M1.24%β€”β€”
1.2%
ALDXALDEYRA THERAPEUTICS INC$39.5M1.24%$3.99$2.27-43.1%
1.2%
NBIXNEUROCRINE BIOSCIENCES INC$38.8M1.21%$97.48$174.26+78.8%
1.2%
RAPTRAPT THERAPEUTICS INC$34.9M1.09%β€”β€”
1.1%
RLAYRELAY THERAPEUTICS INC$32.5M1.02%$16.75$18.65+11.3%
1.0%
LLYLILLY ELI & CO$32.4M1.02%$313.65$1213.91+287.0%
1.0%
COHERUS BIOSCIENCES INC$29.5M0.92%β€”β€”
0.9%
COGTCOGENT BIOSCIENCES INC$27.9M0.87%$9.02$38.69+328.9%
0.9%
CHRSCOHERUS BIOSCIENCES INC$26.4M0.83%$7.24$1.45-80.0%
0.8%
MDGLMADRIGAL PHARMACEUTICALS INC$26.3M0.82%$71.58$528.10+637.8%
0.8%
ALNYALNYLAM PHARMACEUTICALS INC$25.2M0.79%$145.85$312.78+114.5%
0.8%

Quarter-on-Quarter Activity

Q2 2022 vs. Q1 2022

New Positions (8)

TickerIssuerNotionalSince Filing
SGENSEAGEN INC$39.6M
LLYLILLY ELI & CO$32.4M+287.0%
ACLXARCELLX INC$20.6M
HRMYHARMONY BIOSCIENCES HLDGS IN$20.1M
BMRNBIOMARIN PHARMACEUTICAL INC$14.9M
HLVXHILLEVAX INC$8.4M
XBIPUTSPDR SER TR$7.4M
YMABY-MABS THERAPEUTICS INC$3.2M

Exited Positions (8)

TickerIssuerNotional
AGRXXXXXAGILE THERAPEUTICS INC$178.4M
HZNPHORIZON THERAPEUTICS PLC$142.9M
COLLEGIUM PHARMACEUTICAL INC$89.5M
NVRONEVRO CORP$34.5M
PENPENUMBRA INC$31.9M
ZNTLZENTALIS PHARMACEUTICALS INC$23.1M
LEGNLEGEND BIOTECH CORP$22.4M
AXNXAXONICS INC$21.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RVNCREVANCE THERAPEUTICS INC$5.2M+316.3%
LYRAXXXXLYRA THERAPEUTICS INC$38.7M+183.8%
AMLXAMYLYX PHARMACEUTICALS INC$49.3M+140.2%-5.1%
WGSSEMA4 HOLDINGS CORP$-1.4M+100.0%
AORTARTIVION INC$4.4M+51.0%
ATHAATHIRA PHARMA INC$-31.6M+40.0%
VRCAVERRICA PHARMACEUTICALS INC$-19.6M+39.6%
MDGLMADRIGAL PHARMACEUTICALS INC$-1.0M+32.1%+637.8%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
SRZNSURROZEN INC$-0.2M-92.3%
PRVBPROVENTION BIO INC$-5.3M-86.0%
APLSAPELLIS PHARMACEUTICALS INC$-60.8M-78.3%
CCXICHEMOCENTRYX INC$-30.6M-73.3%
TVTXTRAVERE THERAPEUTICS INC$-33.8M-69.1%
CCCCC4 THERAPEUTICS INC$-44.8M-63.2%
ISEEIVERIC BIO INC$-67.9M-60.0%
BBIOBRIDGEBIO PHARMA INC$-23.6M-55.8%
← Back to Hedge Funds